Drugs Made In America Acquisition II Corp. (DMII)
10.22
+0.02
(+0.15%)
USD |
NASDAQ |
Nov 04, 16:00
Drugs Made In America Acquisition II EPS Diluted (Quarterly) : 0.069 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.069 |
| March 31, 2026 | 0.0681 |
| December 31, 2025 | 0.0672 |
| September 30, 2025 | -0.0007 |
| Date | Value |
|---|---|
| June 30, 2025 | -0.0006 |
| March 31, 2025 | -0.0009 |
| September 30, 2024 | -0.0006 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Acme United Corp. | 0.80 |
| American Shared Hospital Services | -0.0748 |
| Avalon Holdings Corp. | 0.2267 |
| Flanigan's Enterprises, Inc. | 1.109 |
| Bar Harbor Bankshares | 0.9561 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 4.396M |
| Total Expenses (Quarterly) | -4.396M |
| Enterprise Value | 651.61M |
| Earnings Yield | 1.99% |
| Normalized Earnings Yield | 1.932 |